Navigation Links
Two Distinct Types of Vocal Cord Dysfunction Identified

Two distinct phenotypes of vocal cord dysfunction (VCD) – an involuntary functional disorder during inspiration often misdiagnosed as asthma – were identified// in a long-term study published in the current issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI).

Investigators at the Pediatric Allergy and Pulmonary Division at the University of Iowa College of Medicine in Iowa City, Iowa, conducted a retrospective medical record review of 49 patients seen in the clinic who were diagnosed as having VCD. During the 13-year period, they observed two distinct clinical phenotypes: one group had VCD triggered only by exercise and the second group had spontaneous onset of symptoms not caused by exercise.

Devang R. Doshi, M.D., and Miles M. Weinberger, M.D., observed that speech therapy, the currently accepted preferred intervention, was recommended for all patients in the spontaneous VCD group. For patients with exercised-induced symptoms, seven were prescribed a metered-dose inhaler containing a short-acting anticholinergic agent, and the remainder received no treatment.

Authors noted that the diagnosis of VCD was based on "direct laryngoscopy, reversible inspiratory airflow obstruction with spirometry during observed symptoms, or a convincing history of episodic inspiratory stridor that was rapid in onset and rapidly reversible in the absence of any other findings."

The symptoms of VCD can be mistaken for asthma because both can include labored breathing, an inspiratory noise often described as wheezing, chest tightening and shortness of breath. In VCD the symptoms are a result of an abnormal closing of the vocal cords rather than inflammation of the airways, as in asthma.

Of the 49 patients in the original study population, 41 had previously been diagnosed as having asthma as a cause of their symptoms before the diagnosis of VCD w as established. Asthma was confirmed as a comorbidity in 12 of those patients.

The study also demonstrated that once diagnosed the long-term outcome of VCD is quite good. From the results of a structured telephone interview in 28 of the children and adolescents, the authors reported a complete absence of symptoms in 26 of the 28 contacted patients, at times ranging from one week to five years after the diagnosis.

"The positive outcomes data underscore that VCD appears to be a self-limited disorder once the diagnosis is made," wrote guest editorial author Michael O'Connell, M.D., of the University of Colorado Health Sciences Center in Aurora, Co. "This should energize us to encourage our colleagues in allergy-immunology and primary care to learn the characteristic presentations of this disorder so that the diagnosis can be made without delay."

(Source: Newswise)
'"/>




Related medicine news :

1. Distinct Brain Sections Are Activated While Making Risky Decisions
2. Distinct Support Services Needed, To Resurrect Ethnic Groups from Alcohol Abuse
3. Sunlight Could Be Beneficial For Certain Types Of Cancer
4. Different Types Of Multiple Sclerosis May Be Treated Differently
5. Implants In The Ear Is Effective Against All Types Of Hearing Loss
6. Placing a Finger on Responses to Placebo Types
7. Higher Risk for Cervical Cancer Seen Among Women Infected with Multiple HPV Types
8. Ultraviolet B (UVB) Radiation Reduces Risk of 16 Types of Cancer in U.S.
9. Human Skin Harbors Many More Types of Bacteria
10. New Test May Better Identify Certain Colorectal Cancer Types
11. Dysfunction of Vocal Cord Often Misdiagnosed for Asthma
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/18/2017)... ... February 18, 2017 , ... ... the latest information and contact points to easily connect elderly veterans of America's ... living, and elder-care funding. It also conveys material on this year's increase in ...
(Date:2/17/2017)... San Diego, CA (PRWEB) , ... February 17, ... ... new initiative—InvestUp—to focus on foundational and sustainable systems change designed to further positively ... Counties. , “The Board of Trustees has long considered it our duty to ...
(Date:2/17/2017)... Falls Church, VA (PRWEB) , ... ... ... to Integrate FDA Device Approval and Reimbursement , **An FDAnews Webinar**, Feb. ... , What are the critical reimbursement questions manufacturers should be asking ...
(Date:2/17/2017)... WA (PRWEB) , ... February 17, 2017 , ... ... management organizations, has been named a finalist in the 8th Annual DecisionHealth Platinum ... America's healthcare delivery system. Qualis Health’s work is recognized across multiple award categories, ...
(Date:2/17/2017)... Austin, Tx (PRWEB) , ... February 17, 2017 ... ... of revenue cycle management services, announced today that Karen Pilley has been promoted ... expenses is critical in today’s shifting healthcare paradigm – a shift that demands ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... 17, 2017 According to a new market ... Particle Counters), Application (Cleanroom Monitoring, Contamination Monitoring of Liquids), and End ... by MarketsandMarkets, the market is expected to reach USD 330.6 Million ... of 3.7% from 2016 to 2021. ... ...
(Date:2/17/2017)... , Feb. 17, 2017  Perrigo Company plc (NYSE, TASE: ... U.S. Food and Drug Administration for hydrocodone bitartrate and homatropine ... Hydrocodone bitartrate and homatropine methylbromide oral solution ... the symptomatic relief of cough in adults and children 6 ... months ending January 2017 were approximately $16 million.   ...
(Date:2/17/2017)... NEW YORK , Feb. 17, 2017   ... other side effects allegedly associated with use of the ... Philadelphia Court of Common Pleas, ... a mass tort program. According to a notice posted ... scheduled to convene a meeting on March 9, 2017 ...
Breaking Medicine Technology: